LAS VEGAS, Dec. 31, 2002 (PRIMEZONE) -- August Biomedical Corporation (formerly "Coyote Ventures Corp.") (OTCBB:AGBM) (the "Company") announces today that its name change from Coyote Ventures Corp. to August Biomedical Corporation is effective today. The shares of the Company are expected to commence trading under the new symbol "AGBM" on the OTC Bulletin Board on Thursday, January 2, 2003. Shareholders do not need to exchange their share certificates as a result of the change in name, but may do so by forwarding them to the Company's transfer agent, Pacific Stock Transfer Company, together with the request for a new share certificate.
Public Company Disclosure
This document may contain certain forward-looking statements regarding Coyote Ventures Inc. including statements about its operations, prospects and expectations about future financial results, including, but not limited to, future revenues and earnings. The words "estimate," "possible," "expects," "anticipates," "believes," "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. These forward-looking statements involve risks and uncertainties, which could cause actual results to differ materially and are subject to change at any time. The Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Investors are cautioned that all forward-looking statements involve risk and uncertainties, including those risks and uncertainties detailed in the Company's Annual Report on Form 10-KSB for the year ended December 31, 2001 filed with the SEC as well as subsequent forms 8-Ks, 10-Qs, 14-C and S-8 registrations.